The global demographic shift towards an ageing population presents a significant public health challenge, particularly the increasing prevalence of neurodegenerative diseases and functional limitations in older adults [1]. Among these, dementia stands out as a significant contributor to disability in the elderly population [2]. This multifaceted syndrome is characterised by a persistent and irreversible decline […]
Optimal nutrition is a fundamental right of every child and is essential for promoting physical growth, development, and overall well-being [1]. Despite global efforts, stunting remains a pressing issue, with 22.3% of children under five years affected worldwide. Asia accounts for 52% of the global burden of stunting and over 75% of children are classified […]
26 July 2024 in Cellular and Molecular Neurobiology
Optogenetics, a revolutionary technique integrating optical and genetic methodologies, offers unparalleled precision in spatial targeting and temporal resolution for cellular control. This approach enables the selective manipulation of specific neuronal populations, inducing subtle electrical changes that significantly impact complex neural circuitry. As optogenetics precisely targets and modulates neuronal activity, it holds the potential for significant breakthroughs in understanding and potentially altering the course of neurodegenerative diseases, characterized by selective neuronal loss leading to functional deficits within the nervous system. The integration of optogenetics into neurodegenerative disease research has significantly advanced in the field, offering new insights and paving the way for innovative treatment strategies. Its application in clinical settings, although still in the nascent stages, suggests a promising future for addressing some of the most challenging aspects of neurodegenerative disorders. In this review, we provide a comprehensive overview of these research undertakings.
Hypertension is a critical public health issue and a leading cause of cardiovascular disease, morbidity, and premature mortality worldwide [1]. About 1.13 billion people – one in six globally – are affected by high blood pressure (BP), a figure which is projected to increase to 1.5 billion by 2025 [2]. Despite growing awareness, less than […]